Risperidone
- Product NDC
- 59746-010
- 11-digit product format
- 597460010
- Labeler code
- 59746
- Product ID
- 59746-010_90b80768-87f7-4fb1-8142-909dba9555e2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Risperidone
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Jubilant Cadista Pharmacuticals Inc.
- Application
- ANDA090839
- Marketing category
- ANDA
- Marketing start
- 2011-11-04
- Substance
- RISPERIDONE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Risperidone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RISPERIDONE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | L6UH7ZF8HC |
| Rxcui | 401953, 401954, 403825, 616698, 616705 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 59746-010-22 | 2023-02-28 | C162847 | 48780-1 | f386c64a-099c-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use RISPERIDONE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for RISPERIDONE ORALLY DISINTEGRATING TABLETS. RISPERIDONE orally disintegrating tablets, for oral use Initial U.S. Approval: 1993 |
| 59746-010-22 | 2023-02-28 | C162847 | 48780-1 | f386c64a-099c-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use RISPERIDONE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for RISPERIDONE ORALLY DISINTEGRATING TABLETS. RISPERIDONE orally disintegrating tablets, for oral use Initial U.S. Approval: 1993 |
| 59746-010-32 | 2023-02-28 | C162847 | 48780-1 | f386c64a-099c-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use RISPERIDONE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for RISPERIDONE ORALLY DISINTEGRATING TABLETS. RISPERIDONE orally disintegrating tablets, for oral use Initial U.S. Approval: 1993 |
| 59746-010-32 | 2023-02-28 | C162847 | 48780-1 | f386c64a-099c-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use RISPERIDONE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for RISPERIDONE ORALLY DISINTEGRATING TABLETS. RISPERIDONE orally disintegrating tablets, for oral use Initial U.S. Approval: 1993 |
| 59746-010-22 | 2023-01-30 | C162847 | 48780-1 | f386c64a-099c-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use RISPERIDONE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for RISPERIDONE ORALLY DISINTEGRATING TABLETS. RISPERIDONE orally disintegrating tablets, for oral use Initial U.S. Approval: 1993 |
| 59746-010-22 | 2023-01-30 | C162847 | 48780-1 | f386c64a-099c-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use RISPERIDONE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for RISPERIDONE ORALLY DISINTEGRATING TABLETS. RISPERIDONE orally disintegrating tablets, for oral use Initial U.S. Approval: 1993 |
| 59746-010-32 | 2023-01-30 | C162847 | 48780-1 | f386c64a-099c-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use RISPERIDONE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for RISPERIDONE ORALLY DISINTEGRATING TABLETS. RISPERIDONE orally disintegrating tablets, for oral use Initial U.S. Approval: 1993 |
| 59746-010-32 | 2023-01-30 | C162847 | 48780-1 | f386c64a-099c-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use RISPERIDONE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for RISPERIDONE ORALLY DISINTEGRATING TABLETS. RISPERIDONE orally disintegrating tablets, for oral use Initial U.S. Approval: 1993 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59746-010-22 | Risperidone | 7 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 7 | | 25 |
| 59746-010-22 | Risperidone | 4 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 4 | | 25 |
| 59746-010-32 | Risperidone | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | | 25 |
| 59746-010-32 | Risperidone | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | | 25 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Risperidone | ACTIVE INGREDIENT | L6UH7ZF8HC | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Risperidone | ACTIVE MOIETY | L6UH7ZF8HC | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Acesulfame Potassium | INACTIVE INGREDIENT | 23OV73Q5G9 | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Dimethylaminoethyl Methacrylate - Butyl Methacrylate - Methyl Methacrylate Copolymer | INACTIVE INGREDIENT | 905HNO1SIH | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Fd&c Blue No. 1 | INACTIVE INGREDIENT | H3R47K3TBD | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Fd&c Yellow No. 6 | INACTIVE INGREDIENT | H77VEI93A8 | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Ferric Oxide Red | INACTIVE INGREDIENT | 1K09F3G675 | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Ferric Oxide Yellow | INACTIVE INGREDIENT | EX438O2MRT | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Hydroxypropyl Cellulose, Low Substituted | INACTIVE INGREDIENT | 2165RE0K14 | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Magnesium Aluminometasilicate Type I-a | INACTIVE INGREDIENT | 7LVU907546 | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Mannitol | INACTIVE INGREDIENT | 3OWL53L36A | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Peppermint | INACTIVE INGREDIENT | V95R5KMY2B | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Sodium Lauryl Sulfate | INACTIVE INGREDIENT | 368GB5141J | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Sodium Stearyl Fumarate | INACTIVE INGREDIENT | 7CV7WJK4UI | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
| Talc | INACTIVE INGREDIENT | 7SEV7J4R1U | RISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.] | 11 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59746-010 | RISPERIDONE TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACUTICALS INC.] | 24 | Current NDC, Legacy NDC, 4 package rows | 20250519_739dcf8a-ed73-5eb0-899b-7e51cb73c335.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59746-010-22 | 59746001022 | 7 BLISTER PACK in 1 CARTON (59746-010-22) / 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 7 blister pack | 2011-11-04 | 0000-00-00 | No | No | Current |
| 59746-010-32 | 59746001032 | 3 BLISTER PACK in 1 CARTON (59746-010-32) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 3 blister pack | 2011-11-04 | 0000-00-00 | No | No | Current |